Our Recommendations
- Когда забыть не получается Информационная брошюра о посттравматическом стрессовом расстройстве (2014)
- Коли не вдається забути Інформаційна брошура щодо посттравматичного стресового розладу (2014)
- Gut mit Stress und Belastungen umgehen: ein illustriertes Übungsbuch (2020)
- Faire ce qui compte en période de stress (2020)
- Post-traumatic stress disorder: NICE guideline (2019)
New Publications
- Інформація для батьків про благополуччя та зменшення стресу (2023)
- Информация для родителей о благополучии и снижении стресса (2023)
- How to ... Manage anxiety and fear (2022)
- Когда забыть не получается Информационная брошюра о посттравматическом стрессовом расстройстве (2014)
- Коли не вдається забути Інформаційна брошура щодо посттравматичного стресового розладу (2014)
Filter
282
Featured
Recommendations
35
New Publications
19
Language
Document type
No document type
170
Studies & Reports
23
Guidelines
21
Manuals
19
Brochures
16
Fact sheets
10
Training Material
8
Resource Platforms
7
Infographics
7
Videos
1
Countries / Regions
Ukraine
22
Russia
21
Western and Central Europe
13
Germany
11
Global
10
Eastern Europe
10
India
10
Switzerland
4
Latin America and the Carribbean
4
Syria
3
Nepal
2
Estonia
2
USA
2
Africa
2
Asia
2
South Africa
2
Sri Lanka
2
Ethiopia
2
South Sudan
2
Tajikistan
1
Albania
1
Peru
1
Zimbabwe
1
Philippines
1
Eastern Europe and Central Asia
1
United Kingdom
1
Argentina
1
Yemen
1
Romania
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
29
Clinical Guidelines
6
Capacity Building
3
Women & Child Health
1
Pharmacy & Technologies
1
Цель: анализ уровня тревожности и тяжести депрессии у больных рассеянным склерозом. Материал и методы. Чтобы определить уровень депрессии и тревожности у больных ...
Mood disorders
Chapter E.2
Other disorders
Chapter H.5
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
Roubles de l’humeur
Chapitre E.4
Edition en français Traduction : Cora Cravero Sous la direction de : David Cohen Avec le soutien de la SFPEADA
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Learning objectives
• Promote respect and dignity for people with self-harm/suicide.
• Know the common presentations of self-harm/suicide.
• Know the principles of assessment of self-harm/suicide.
• Know the management principles of self-harm/suicide.
• Perform an assessment for self-...
Q 4: Is behavioural activation better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with de...
The number of general health staff skilled in psychological treatment for depression is limited, and learning psychological treatments tends to require considerable training and supervision. Relaxation may be a relatively simple form of psychological treatment. It has been frequently studied in rese...
Q6: Is advice on physical activity better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder with inactive lifestyles
Depression Research and Treatment
Volume 2012, Article ID 962860, 8 pages
doi:10.1155/2012/962860
The Georgetown Undergraduate Journal of Health Services (2), 2012.
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic only?
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
